| INNATE PHARMA EO -,05 |
| Frankreich |
| Gesundheit |
| FR0010331421 / A0LCUJ |
| IDD (Frankfurt) |
| FRA:IDD, ETR:IDD, IDD:GR |
| - |
| https://www.innate-pharma.. |
|
Innate Pharma S.A. is a global, clinical-stage biotechnology company specializing in oncology-focused immunotherapies that harness the innate immune system to combat cancer. Founded in 1999 by pioneers in innate immunity, the company leverages expert..
>Volltext.. |
| 138.06 Mio. EUR |
| 147.37 Mio. EUR |
| 4.39 Mio. EUR |
| -53.91 Mio. EUR |
| -49.29 Mio. EUR |
| -0.53 EUR |
| 20.99 Mio. EUR |
| 6.71 Mio. EUR |
| -43.88 Mio. EUR |
| 0.33 |
| -29.48% |
| -3.05% |
| - |
| - |
| - |
| - |
| INNATE PHARMA |
| 18.11.26 |
|